|
|
||||||||
1From the Department of Anatomy and Cell Biology and the 2Kresge Eye Institute, Wayne State University, Detroit, Michigan.
PURPOSE. To determine the spatial pattern and temporal evolution of the change in retinal partial oxygen pressure (
PO2) associated with a murine oxygen-induced retinopathy (OIR) model of retinal neovascularization (NV).
METHODS. On P7, newborn C57BL/6 mice were exposed to 75% oxygen until postnatal day (P)12, followed by recovery in room air until P17 or P34. Control mice remained in room air until P17 or P34. At P17 and P34, functional magnetic resonance imaging (MRI) and a carbogen inhalation challenge was used to measure retinal
PO2. Retinal avascularity, distance from the optic nerve head to the vascular edge in the peripheral retina, and NV incidence and severity were measured in retinas stained with adenosine diphosphatase (ADPase).
RESULTS. In P17 and P34 controls and in P34 OIR animals, retinas were fully vascularized without evidence of NV. In P17 OIR mice, there was a large central retinal capillary-free zone (22% ± 3% of the entire retinal area, mean ± SD) and 4 clockhours (range 17) of retinal NV at the border of the peripheral vascular and central acapillary retina in 100% (36/36) of the mice. In P17 OIR mice, retinal
PO2 over the vascularized far peripheral retina was not significantly (P > 0.05) different from the P17 control but was supernormal (P < 0.05) over the central capillary-free retina. However, no differences (P > 0.05) in retinal
PO2 were found between the P34 control and OIR groups.
CONCLUSIONS. A reversible supernormal
PO2 was found only over the central acapillary retina during the appearance of retinal NV in a mouse OIR model. The present data show the applicability of carbogen-challenge functional MRI to the study of retinal
PO2 in vivo in eyes that are too small for the use of existing techniques.
This article has been cited by other articles:
![]() |
G. L. Trick, P. Edwards, U. Desai, and B. A. Berkowitz Early supernormal retinal oxygenation response in patients with diabetes. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1612 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Luan, R. Roberts, M. Sniegowski, D. J. Goebel, and B. A. Berkowitz Retinal Thickness and Subnormal Retinal Oxygenation Response in Experimental Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 320 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kolodjaschna, F. Berisha, S. Lung, H. Schima, E. Polska, and L. Schmetterer Comparison of the Autoregulatory Mechanisms between Middle Cerebral Artery and Ophthalmic Artery after Thigh Cuff Deflation in Healthy Subjects Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 636 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Franklin, T. L. Jetton, C. L. Kuchemann, S. R. Russell, and E. C. Kohn CAI Is a Potent Inhibitor of Neovascularization and Imparts Neuroprotection in a Mouse Model of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3756 - 3766. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |